Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.

Patient Prefer Adherence · 2013 · PMC3790868 · PMID 24101863

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

near statistical significanceP = 0.057so close (0.05 < p ≤ 0.1)

In the Czech registry, 26 there were no differences in survival rates between the anti-TNF agents, although the difference between etanercept and infliximab was near statistical significance ( P = 0.057).

also in 222 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.